Laura L. Worth

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

30h-index3.5kcitations102works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(43), Acute Lymphoblastic Leukemia research(25), Acute Myeloid Leukemia Research(16), Chronic Myeloid Leukemia Treatments(16), Polyomavirus and related diseases(15)

Publications101 total

Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes—The <scp>MD</scp> Anderson Cancer Center experience
Pediatric Transplantation·2017· 12 cited
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients
Bone Marrow Transplantation·2016· 83 citedOpen Access
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
Stem Cells·2016· 124 citedOpen Access
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation·2016· 20 citedOpen Access
Incidence and Outcome of Early Hospital Readmission Following Hematopoetic Stem Cell Transplantation in Pediatric and Young Adult Patients
Biology of Blood and Marrow Transplantation·2015· 2 citedOpen Access
Spinal Cord Injection of Stem Cells for Pediatric ALS
Biology of Blood and Marrow Transplantation·2015Open Access
Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children*
Pediatric Critical Care Medicine·2015· 76 citedOpen Access
Exploring the Cancer Experiences of Young Adults in the Context of Stem Cell Transplantation
Cancer Nursing·2014· 2 citedOpen Access
Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children
Journal of the American College of Surgeons·2014· 4 cited
Is there an expiration date for a cord blood unit in storage?
Bone Marrow Transplantation·2014· 9 citedOpen Access
Clofarabine ± Fludarabine with IV Busulfan and Allogeneic Stem Cell Transplantation for Advanced Myeloid Leukemia (ML) and MDS
Biology of Blood and Marrow Transplantation·2014Open Access
Is There An Expiration Date For Cord Blood Units In Storage?
Blood·2013· 1 cited
The Development of a Myeloablative, Reduced-Toxicity, Conditioning Regimen for Cord Blood Transplantation
Clinical Lymphoma Myeloma & Leukemia·2013· 21 citedOpen Access
Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin
Clinical Lymphoma Myeloma & Leukemia·2013· 58 citedOpen Access
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture
New England Journal of Medicine·2012· 472 citedOpen Access
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia
Bone Marrow Transplantation·2012· 52 citedOpen Access
High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphoid Malignancies
Biology of Blood and Marrow Transplantation·2012· 52 citedOpen Access
Outcomes of second allogeneic hematopoietic stem cell transplantation (SCT) for patients with acute lymphoblastic leukemia (ALL).
Journal of Clinical Oncology·2012· 1 cited
Inotuzumab Ozogamicin (IO) Is An Effective Salvage Therapy That Allows for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Remission in Patients with Advanced Acute Lymphoblastic Leukemia (ALL)
Blood·2011· 5 cited
Pharmacokinetic Dose Guidance of IV Busulfan with Fludarabine with Allogeneic Stem Cell Transplantation Improves Progression Free Survival in Patients with AML and MDS; Results of a Randomized Phase III Study
Blood·2011· 7 cited
page 1 of 6Next →

Frequent Co-authors

Eugenie S. Kleinerman(17), Richard E. Champlin(16), Elizabeth J. Shpall(14), Partow Kebriaei(13), Gabriela Rondón(12), Uday Popat(11), Roy B. Jones(10), Marcos de Lima(9), Chitra Hosing(9), Amin M. Alousi(8), Börje S. Andersson(8), Muzaffar H. Qazilbash(8), Demetrios Petropoulos(8), Shu-Fang Jia(8), Yago Nieto(7), Laurence J.N. Cooper(6), Stefan O. Ciurea(6), Dean A. Lee(6), Rima M. Saliba(5), Ian McNiece(4)